[1]林雨璇,孔为民*.宫颈癌患者生活质量研究进展[J].中国计划生育和妇产科,2020,(6):9-11,15.
点击复制

宫颈癌患者生活质量研究进展
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年6期
页码:
9-11,15
栏目:
宫颈病变诊治专栏
出版日期:
2020-06-25

文章信息/Info

作者:
林雨璇; 孔为民*
首都医科大学附属北京妇产医院妇瘤科
关键词:
宫颈癌;  生活质量;  影响因素; 措施
分类号:
R 47373

参考文献/References:

［1］Neerja Bhatla, Daisuke Aoki, Daya Nand Shama, et al. Cancer of the cervix uteri ［J］. Int J Gynecol Obstet，2018, 143 (Suppl 2):S 22S 36. ［2］Berek JS, Matsuo K, Grubbs BH, et al. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri ［J］. Journal of Gynecologic Oncology, 2019, 30(2): e 40. ［3］The WHOQOL Group.The World Health Organization Quality of Life assessment (WHOQOL):development and general psychometric properties ［J］.Social Science & Medicine,1998,46(12):15691585. ［4］Thapa N, Muna M, Yan Xiong, et al. Impact of cervical cancer on quality of life of women in Hubei, China ［J］. Scientific Reports, 2018, 8(1): 11993. ［5］Zeng Yingchun, Cheng A S, Liu Xiangyu, et al. Cervical cancer survivors' perceived cognitive complaints and supportive care needs in mainland China: a qualitative study ［J］. BMJ Open, 2017, 7(6): e 014078. ［6］Lu Qian, You Jin, Kavanagh A, et al. Differences in quality of life between American and Chinese breast cancer survivors ［J］. Supportive Care in Cancer:Official Journal of the Multinational Association of Supportive Care in Cancer, 2016, 24(9): 37753782. ［7］Huang H Y, Tsai W C, Chou Wenyu, et al. Quality of life of breast and cervical cancer survivors ［J］. BMC Women's Health, 2017, 17(1): 30. ［8］Li Faping, Guo Hui, Qiu Heping, et al. Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer ［J］. Medicine, 2018, 97(13): e 0173. ［9］Seon H P, JungYun L, Eun J N, et al. Prediction of perioperative complications after roboticassisted radical hysterectomy for cervical cancer using the modified surgical Apgar score ［J］. BMC Cancer, 2018, 18(1): 908. ［10］Xue Zhuowei, Zhu Xiaolu, Teng Yincheng. Comparison of nervesparing radical hysterectomy and radical hysterectomy: a systematic review and MetaAnalysis ［J］. Cellular Physiology and Biochemistry, 2016, 38(5): 18411850. ［11］Pfaendler K S, Wenzel L, Mechanic M B, et al. Cervical cancer survivorship: longterm quality of life and social support ［J］. Clinical Therapeutics, 2015, 37(1): 3948. ［12］Vermeulen R M, Beurden M V, Korse C M, et al. Impact of riskreducing salpingooophorectomy in premenopausal women ［J］. Climacteric, 2017, 20(3): 212221. ［13］Rubinsak L A, Kang Le, Fields E C, et al. Treatmentrelated radiation toxicity among cervical cancer patients ［J］. International Journal of Gynecological Cancer, 2018, 28(7): 13871393. ［14］Salih S M, Albayrak S, Seo S, et al. Diminished utilization of in vitro fertilization following ovarian transposition in cervical cancer patients ［J］. Journal of Reproductive Medicine, 2015, 60(7/8): 345353. ［15］阮祥燕，程姣姣，杜娟，等．卵巢组织冻存与移植对宫颈癌患者卵巢内分泌功能的影响 ［J］．中国临床医生杂志，2019，47（7）：759762． ［16］Nicholas S, Chen Linda, Choflet A, et al. Pelvic radiation and normal tissue toxicity ［J］. Seminars in Radiation Oncology, 2017, 27(4): 358369. ［17］Wright J D, June Y H, William M B, et al. Utilization and toxicity of alternative delivery methods of adjuvant chemotherapy for ovarian cancer ［J］. Obstetrics & Gynecology, 2016, 127(6): 985991. ［18］Hanprasertpong J, Geater A, Jiamset I A, et al. Fear of cancer recurrence and its predictors among cervical cancer survivors ［J］. Journal of Gynecologic Oncology, 2017, 28(6): e 72. ［19］Yumi Lee, Myong C L, Se I K, et al. Comparison of quality of Life and sexuality between cervical cancer survivors and healthy women ［J］. Cancer Research and Treatment, 2016, 48(4): 13211329. ［20］Ingluen S, Hu Liyu, Yijen C, et al. Risk factors for developing depression in women with cervical cancer: a nationwide populationbased study in Taiwan ［J］. International Journal of Women's Health, 2019, 11(2): 135141. ［21］Hock M, Farkas N, Tiringer I, et al. Validation and translation of the Hungarian version of the Female Sexual Function Index (FSFIH) ［J］. International Urogynecology Journal, 2019, 30(12): 21092120. ［22］Villar R R, Fernández S P, Cereijo G C , et al. Quality of life and anxiety in women with breast cancer before and after treatment ［J］. Revista LatinoAmericana de Enfermagem, 2017, 25: 2958. ［23］Finkelstein F O, Nooten F V, Wiklund I, et al. Measurement properties of the Short Form36 (SF36) and the Functional Assessment of Cancer Therapy  Anemia (FACTAn) in patients with anemia associated with chronic kidney disease ［J］. Health and Quality of Life Outcomes, 2018, 16(1): 111. ［24］薛凤霞，滕飞，魏丽坤．妇科恶性肿瘤保留生育功能生育结局 ［J］．中国实用妇科与产科杂志，2019，35（6）：646651． ［25］Chao Xiaopei, Lei Li, Ming Wu, et al. Efficacy of different surgical approaches in the clinical and survival outcomes of patients with earlystage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China ［J］. BMJ Open, 2019, 9(7): e 029055. ［26］Ramirez P T, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer ［J］. New England Journal of Medicine, 2018, 379(20): 18951904. ［27］Marjanovic D,Plesinac Karapandzic V,Stojanovic Rundic S,et al.Implementation of intensitymodulated radiotherapy and comparison with threedimensional conformal radiotherapy in the postoperative treatment of cervical cancer ［J］. J BUON, 2019, 24(5): 20282034. ［28］田苗，田丹，林杨，等．中药对宫颈癌放疗后并发症预防与治疗的研究进展 ［J］．长春中医药大学学报，2019，35（4）：809812． ［29］Meng Fanfeng, Feng Yanhong. A pilot study of acupuncture at pain acupoints for cervical cancer pain ［J］. Medicine, 2018, 97(52): e 13736. ［30］Baettig F, Tatjana V, Vetter M, et al. Nivolumab in chemotherapyresistant cervical cancer: report of a vulvitis as a novel immunerelated adverse event and molecular analysis of a persistent complete response ［J］. Journal for Immunotherapy of Cancer, 2019, 7(1): 281. ［31］Musa J, Achenbach C J, O'Dwyer L C, et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and metaanalysis ［J］. PLOS One, 2017, 12(9): e 0183924. ［32］Li Jue, Huang Jiliang, Jun Zhang, et al. A homebased, nurseled health program for postoperative patients with earlystage cervical cancer: A randomized controlled trial ［J］. European Journal of Oncology Nursing, 2016, 21(4): 174180. ［33］奚兰花，张小萍．循证护理对宫颈癌患者放疗后并发症与生活质量的影响 ［J］．护理实践与研究，2019，16（13）：101103． ［34］郑亚娜，温雪云，池燕平．责任制延续性护理干预在宫颈癌化疗患者中的应用效果 ［J］．国际护理学杂志，2019，38（17）：28762880．

相似文献/References:

[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
　FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(6):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
　GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(6):0.
[4]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
　XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(6):0.
[5]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
　ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[6]安红梅,张雯,邓继红,等.昆明地区高危HPV病毒载量与宫颈病变和宫颈癌相关性[J].中国计划生育和妇产科,2013,(03):0.
　AN Hong - mei,ZHANG Wen,DENG Ji - hong *,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[7]闵爱萍,谢桂清,冷开容,等.Hepsin、Maspin在宫颈疾病中的表达及其临床意义[J].中国计划生育和妇产科,2013,(06):0.
　Min Ai-ping,Xie Gui-qing,Leng Kai-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[8]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[9]闵爱萍.刺猬蛋白在宫颈癌组织中的表达及其临床意义[J].中国计划生育和妇产科,2014,(07):0.
　MIN Ai-ping,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(6):0.
[10]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.

更新日期/Last Update: 2020-06-25